Skip to main content
. 2022 Aug 6;195(3):367–377. doi: 10.1007/s10549-022-06691-4

Table 3.

Survival rates depending on molecular subtype

n 5 years 10 years 20 years
OS (%) BCSS (%) OS (%) BCSS (%) OS (%) BCSS (%)
Cumulative survival rates depending on molecular subtype
All 445 94 98 84 96 60 89
LumA 209 95 98 85 97 60 91
LumB 180 94 97 83 96 59 83
TNBC 30 87 89 70 85 53 85
HER2+ 26 96 100 88 91 68 91

OS overall survival, BCSS breast cancer specific survival, LumA Luminal A-like, LumB Luminal B-like (HER2−), TNBC triple negative breast cancer, HER2+ HER2-positive